Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study
Open Access
- 1 May 2019
- journal article
- research article
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 8 (7) , 523-533
Abstract
Aim:To determine measurement equivalence of paper and electronic application of the hematological malignancy-patient-reported outcome (HM-PRO), a specific measure for the evaluation of patient-reported outcomes in HMs.Patients & methods:Following International Society of Pharmacoeconomics and Outcomes Research ePRO Good Research Practice Task Force guidelines, a total of 193 adult patients with different HMs were recruited into a multicenter prospective study. The paper and the electronic version of the instrument were completed in the outpatient clinics in a randomized crossover design with a 30 min time interval to minimize the learning effect. Those who completed the paper version first, completed the electronic version after 30 min and vice versa. Instrument version and order effects were tested on total score of the two parts of the HM-PRO (Part A: quality of life and Part B: signs & symptoms) in a two-way ANOVA with patients as random effects. Intraclass correlation coefficients (95% CI) and Spearman's rank correlation coefficients were used to evaluate test–retest reliability and reproducibility. The effects of instrument version and order were tested on total score of the two parts of HM-PRO.Results:The questionnaire version and administration order effects were not significant at the 5% level. There were no interactions found between these two factors for HM-PRO (Part A [quality of life]; p = 0.95); and (part B [signs and symptoms]; p = 0.72]. Spearman's rank correlation coefficients were greater than 0.9, and intraclass correlation coefficients ranged from 0.94 to 0.98; furthermore, the scores were not statistically different between the two versions, showing acceptable reliability indexes. Noteworthy, the difference between the completion time for both paper (mean = 6:38 min) and electronic version (mean = 7:29 min) was not statistically significant (n = 100; p = 0.11). Patients did not report any difficulty in completing the electronic version during cognitive interviews and were able to understand and respond spontaneously.Conclusion:Measurement equivalence has been demonstrated for the paper and electronic application of the HM-PRO.Keywords
This publication has 13 references indexed in Scilit:
- Development of a Novel Patient-Reported Outcome Measure in Haematological Malignancy for Use in Routine Clinical Practice: Item GenerationBlood, 2016
- Patient-reported outcomes in clinical practiceHematology-American Society Hematology Education Program, 2015
- Patient-reported outcomes: pathways to better health, better services, and better societiesQuality of Life Research, 2015
- Measure once, cut twice—adding patient-reported outcome measures to the electronic health record for comparative effectiveness researchJournal of Clinical Epidemiology, 2013
- Supporting Clinical Practice Decisions With Real-Time Patient-Reported OutcomesJournal of Clinical Oncology, 2011
- The Missing Voice of Patients in Drug-Safety ReportingNew England Journal of Medicine, 2010
- Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures: ISPOR ePRO Good Research Practices Task Force ReportValue in Health, 2009
- Equivalence of Electronic and Paper-and-Pencil Administration of Patient-Reported Outcome Measures: A Meta-Analytic ReviewValue in Health, 2008
- Missing quality of life data in cancer clinical trials: serious problems and challengesStatistics in Medicine, 1998
- The Clinical Record in Medicine Part 1: Learning from CasesAnnals of Internal Medicine, 1991